Molecular Characterization of Multiple Myeloma Ethnic Disparity

Post Date

May 22nd 2015

Application Due Date

July 21st 2015

Funding Opportunity Number

RFA-FD-15-029

CFDA Number(s)

93.103

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health
Information and Statistics

Number of Awards

1

Eligibility Categories

Other

Eligibility is limited to the Multiple Myeloma (MM) service of Memorial Sloan Kettering Cancer Institute.

Funding

• Estimated Total Funding:

  $278000

• Award Range:

  $172000 - $172000

Grant Description

The goal of this funding opportunity is to determine the molecular characteristics of Multiple Myeloma (MM) in patients of Black ethnicity compared to those of White ethnicity. The project will support the FDA's scientific mission of protecting and promoting the public health by initiating and facilitating research into the observed differences in Blacks and the relevance to drug approval and future clinical trial design.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Food and Drug Administration

• Agency Contact:

  Vieda Hubbard
  Grants Management Specialist
  Phone 240-402-7588

• Agency Mailing Address:

  vieda.hubbard@fda.hhs.gov

• Agency Email Address:

  vieda.hubbard@fda.hhs.gov